Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/02/2011 | EP2290076A2 Methods and compositions involving microRNA |
03/02/2011 | EP2290075A2 Methods and compositions involving microRNA |
03/02/2011 | EP2290074A2 Methods and compositions involving microRNA |
03/02/2011 | EP2290073A2 Methods and compositions involving microRNA |
03/02/2011 | EP2290072A2 Methods and compositions involving microRNA |
03/02/2011 | EP2290071A2 Methods and compositions involving microRNA |
03/02/2011 | EP2290070A2 Methods and compositions involving microRNA |
03/02/2011 | EP2290069A2 Methods and compositions involving microRNA |
03/02/2011 | EP2290068A2 Methods and compositions involving microRNA |
03/02/2011 | EP2290067A2 Methods and compositions involving microRNA |
03/02/2011 | EP2290066A2 Methods and compositions involving microRNA |
03/02/2011 | EP2290065A1 Process for production of cis-4-hydroxy-l-proline |
03/02/2011 | EP2290064A1 Proliferative disease detection method |
03/02/2011 | EP2290062A1 Corynebacterium glutamicum gene encoding phosphoenolpyruvate carboxykinase |
03/02/2011 | EP2290060A1 Alpha-amylase variants |
03/02/2011 | EP2290059A1 Lipolytic enzyme variants |
03/02/2011 | EP2290058A1 Lipolytic enzyme variants |
03/02/2011 | EP2290057A2 Variant lipolytic enzymes |
03/02/2011 | EP2290056A2 Mutated Abl kinase domains |
03/02/2011 | EP2290055A2 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic and therapeutic applications |
03/02/2011 | EP2290054A1 Alphavirus particles and methods for preparation |
03/02/2011 | EP2289967A1 Polyhydroxyalkanoate copolymer and manufacturing method therefor |
03/02/2011 | EP2289944A2 Bispecific antibody substituting for functional proteins |
03/02/2011 | EP2289943A1 Antibody capable of discriminating the change in structure between antibody conjugated with antibody and antibody unconjugated with antibody, and method for production of the antibody |
03/02/2011 | EP2289942A2 Anti-HER2 antibody variants |
03/02/2011 | EP2289940A2 Treatment of metastatic disease |
03/02/2011 | EP2289936A1 Immunoglobulin variants and uses thereof |
03/02/2011 | EP2289911A2 Therapeutic use of a growth factor, NsG33 |
03/02/2011 | EP2289910A2 Differential in tumour gene products and use of same |
03/02/2011 | EP2289907A2 Streptococcus agalactiae antigens I + II |
03/02/2011 | EP2289548A2 Combined vaccines comprising hepatitis B surface antigen and other antigens |
03/02/2011 | EP2289531A2 Medicaments for increasing endogenous erythropoietine (EPO) |
03/02/2011 | EP2289311A2 Corn event MIR604 |
03/02/2011 | EP2289309A1 Tomato plants that exhibit resistance to Botrytis cinerea |
03/02/2011 | EP2288720A1 Enzymatic analytical membrane, test device and method |
03/02/2011 | EP2288712A1 Regulation of the expression of a protein in a mammalian cell |
03/02/2011 | EP2288711A1 Methods in increasing grain value by improving grain yield and quality |
03/02/2011 | EP2288710A2 Dgat genes from oleaginous organisms for increased seed storage lipid production and altered fatty acid profiles in in oilseed plants |
03/02/2011 | EP2288709A1 CONTROLLED cDNA OVEREXPRESSION SYSTEM IN ARABIDOPSIS |
03/02/2011 | EP2288708A1 Armyworm insect resistance management in transgenic plants |
03/02/2011 | EP2288707A2 Eukaryotic secretion signal sequence for recombinant expression in prokaryotes |
03/02/2011 | EP2288706A1 Compositions and methods of use of mitogen-activated protein kinase kinase kinase |
03/02/2011 | EP2288705A1 Use of a chimeric gene 4-cl encoding 4-coumarate: coa ligase in brassicaceae |
03/02/2011 | EP2288704A2 Enhancement of drug therapy by mirna |
03/02/2011 | EP2288703A1 Means and methods for counteracting, delaying and/or preventing heart disease |
03/02/2011 | EP2288702A1 Combination therapies against cancer |
03/02/2011 | EP2288701A1 Method for filtering nucleic acids, in particular from fixed tissue |
03/02/2011 | EP2288700A1 Hbv epitope reactive exogenous t cell receptor (tcr) and uses thereof |
03/02/2011 | EP2288697A1 Variants of a family 44 xyloglucanase |
03/02/2011 | EP2288693A1 Novel astrovirus |
03/02/2011 | EP2288623A2 Method of generating single vl domain antibodies in transgenic animals |
03/02/2011 | EP2288621A2 Il-23 receptor antagonists and uses thereof |
03/02/2011 | EP2288620A2 Hybrid proteins comprising membrane receptor and ion channel, and their use as biosensors |
03/02/2011 | EP2288386A1 Modified linkers |
03/02/2011 | EP2288359A1 Genetically modified human umbilical cord perivascular cells for prophylaxis against or treatment of biological or chemical agents |
03/02/2011 | EP2288261A2 Polymeric systems containing intracellular releasable disulfide linker for the delivery of oligonucleotides |
03/02/2011 | EP2288254A1 Herbicide resistant barley |
03/02/2011 | EP2041288B1 Rk2-based broad-host-range cloning vector useful for transfer of metagenomic libraries to a variety of bacterial species |
03/02/2011 | EP2018434B1 Method for performing homologous recombination in plants |
03/02/2011 | EP2004826B1 Improved method for homologous recombination in eukaryotic cells |
03/02/2011 | EP1979481B1 Methods and compositions for ethanol producing cyanobacteria |
03/02/2011 | EP1824969B1 Improved mevalonate kinase |
03/02/2011 | EP1807516B1 Plant promoters and uses thereof |
03/02/2011 | EP1767622B1 Transgenic cell for assay of dioxin and utilizing the same, dioxin detecting method and biosensor |
03/02/2011 | EP1766028B1 Ethanol productivities of saccharomyces cerevisiae strains in fermentation of dilute-acid hydrolyzates depend on their furan reduction capacities |
03/02/2011 | EP1740699B1 Connexin 40 tissue specific gene mutations |
03/02/2011 | EP1650225B1 Hetero type pentamer recombinant vaccine |
03/02/2011 | EP1646656B1 Human antibody molecules for il-13 |
03/02/2011 | EP1587907B1 Kunitz domain library |
03/02/2011 | EP1513937B1 A method for the stimultaneaous production of multiple proteins; vectors and cells for use therein |
03/02/2011 | EP1513934B1 Genes and polypeptides relating to human colon cancers |
03/02/2011 | EP1456390B1 Expression of protective antigens in transgenic chloroplasts and the production of improved vaccines |
03/02/2011 | EP1436403B1 Use of the adenoviral e2 late promoter |
03/02/2011 | EP1383902B1 Overexpression of phosphoenolpyruvate carboxylase |
03/02/2011 | EP1368456B1 Anti-bacterial vaccine compositions |
03/02/2011 | EP1363663B1 Nucleic acid mucosal immunization |
03/02/2011 | EP1287123B1 Subtilisin variant |
03/02/2011 | EP1185662B1 Dna vaccines for dogs |
03/02/2011 | EP1163337B1 Vascular adhesion molecules and modulation of their function |
03/02/2011 | CN1954068B HLA-binding peptide, precursor thereof, DNA fragment encoding the same and recombinant vector |
03/02/2011 | CN1774500B An expression cassette and vector for transient or stable expression of exogenous molecules |
03/02/2011 | CN1748034B Improved expression element |
03/02/2011 | CN1714150B Genetic products differentially expressed in tumors and the use thereof |
03/02/2011 | CN1674935B Biofunctional composition containing CpG or oligo-/polynucleotide and toxin or enterotoxin |
03/02/2011 | CN1646157B Multiple and multivalent DNA vaccines in ovo |
03/02/2011 | CN1507490B Promoters |
03/02/2011 | CN101983241A Use of oligonucleotides with modified bases in hybridization of nucleic acids |
03/02/2011 | CN101983240A Flocculent yeast and method for production thereof |
03/02/2011 | CN101983239A Producing dicarboxylic acids using polyketide synthases |
03/02/2011 | CN101983238A Method for concentration of virus |
03/02/2011 | CN101983207A Anti mif antibodies |
03/02/2011 | CN101983206A Methods for generating marker free transgenic plants |
03/02/2011 | CN101983204A Polypeptide libraries with a predetermined scaffold |
03/02/2011 | CN101983069A Influenza hemagglutinin and neuraminidase variants |
03/02/2011 | CN101983007A Method of producing transformed plant by using agrobacterium strain |
03/02/2011 | CN101982777A Duck plague virus antigen capturing ELISA method based on anti-recombination UL51 albumen antibody |
03/02/2011 | CN101982546A Process for producing dipeptide |
03/02/2011 | CN101982545A Molecular marker SIsv0053 closely linked with millet plant height genes |
03/02/2011 | CN101525671B Highly pathogenic porcine reproductive and respiratory syndrome virus detection reagent kit and application thereof |
03/02/2011 | CN101413012B Method for inducing differentiation of mesenchyma stem cell into islet beta-like cells, and use thereof |